Repligen
(NASDAQ:RGEN)
$186.05
-2.12[-1.13%]
At close: Dec 2(Delayed 15-Minutes)
Get Real Time Here
$186.05
After Hours: 4:08PM EDT
Day Range180.11 - 189.5852 Wk Range137.21 - 292Open / Close184.17 / 186.05Float / Outstanding55.3M / 55.5M
Vol / Avg.389.5K / 633.9KMkt Cap10.3BP/E65.1150d Avg. Price186.46
Div / Yield-Payout Ratio-Total Float55.3MEPS0.73

Repligen Stock (NASDAQ:RGEN), Quotes and News Summary

Repligen Stock (NASDAQ: RGEN) stock price, news, charts, stock research, profile.

Loading...
Day Range180.11 - 189.5852 Wk Range137.21 - 292Open / Close184.17 / 186.05Float / Outstanding55.3M / 55.5M
Vol / Avg.389.5K / 633.9KMkt Cap10.3BP/E65.1150d Avg. Price186.46
Div / Yield-Payout Ratio-Total Float55.3MEPS0.73
Globe Newswire - Oct 12, 2022, 7:30AM
Globe Newswire - Aug 24, 2022, 7:30AM
Globe Newswire - Apr 13, 2022, 7:30AM
Seeking Alpha - Sep 27, 2022, 11:44AM
Seeking Alpha - Aug 24, 2022, 3:01PM
Seeking Alpha - Aug 11, 2022, 2:25PM
InvestorsObserver - Aug 2, 2022, 12:00PM
TipRanks - Jul 25, 2022, 7:43AM
TalkMarkets - Jun 29, 2022, 8:18PM
Seeking Alpha - May 11, 2022, 11:31AM
TipRanks - May 10, 2022, 5:05AM
Sector: Health Care.Industry: Life Sciences Tools & Services
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-16
REV
Q3 2022Est.ActualSurprise
EPS0.6800.770 0.0900
REV192.390M200.741M8.351M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Repligen (RGEN) stock?

A

You can purchase shares of Repligen (NASDAQ: RGEN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Repligen's (RGEN) competitors?

Q

What is the target price for Repligen (RGEN) stock?

A

The latest price target for Repligen (NASDAQ: RGEN) was reported by Stephens & Co. on Wednesday, August 3, 2022. The analyst firm set a price target for 275.00 expecting RGEN to rise to within 12 months (a possible 47.81% upside). 7 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Repligen (RGEN)?

A

The stock price for Repligen (NASDAQ: RGEN) is $186.05 last updated December 2, 2022, 9:00 PM UTC.

Q

Does Repligen (RGEN) pay a dividend?

A

There are no upcoming dividends for Repligen.

Q

When is Repligen (NASDAQ:RGEN) reporting earnings?

A

Repligen’s Q4 earnings are confirmed for Thursday, February 16, 2023.

Q

Is Repligen (RGEN) going to split?

A

There is no upcoming split for Repligen.

Q

What sector and industry does Repligen (RGEN) operate in?

A

Repligen is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.